Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Devices and Getinge have recently announced their partnership under which they will integrate Getinge’s bioreactors with 908 ...

Trinity Biotech (TRIB) announced new findings from its latest pre-pivotal trial, highlighting significant improvements in first-day performance ...

Diabetes device expert Steph Habif said her family's experiment with CGMs shows a big opportunity for wearables: intermittent ...

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...

Glucose monitoring has evolved beyond its traditional role in diabetes management, with an increasing number of people using ...

New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms ...

Environmental monitoring is the repeated measurement of physical, chemical and biological variables in order to study environmental changes, particularly those arising from human activities.

Continuous glucose monitors provide diabetics ... Android Authority The holy grail would be a system as accurate, compact, ...

This ineffective use of insulin causes high blood sugar, which is the main marker of diabetes. The two main types of diabetes are type 1 and type 2. Type 1 diabetes is an autoimmune disease in which ...

Yet there are others with unique properties that affect certain patients. On September 16, 2024, researchers revealed a new blood group system called MAL. This news has medical experts paying close ...